Press release
Radionuclide Scanning Services Market: Global Drivers, Restraints, Opportunities, Trends & Forecast to 2025
Radionuclide scanning also called nuclear medicine imaging is the test that scans internal body parts with the use of radioactive material. This overcomes the limitations of standard X-Ray systems to reach and scan every body part. A radionuclide is used as a label to the substance that accumulates in specific part of the body such as Iodine is used to make thyroid hormones and thus accumulates in the thyroid glands similarly, Diphosphonate accumulates where bone is repairing or rebuilding itself. The tracer is swallowed, inhaled or injected under the skin which emits gamma rays, so the doctors can detect the location of tracer by the use of special scanners or cameras. Highly qualified personnel are required for this process.Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/16639
Radionuclide scanning can be used to visualize images in 2D using Scintigraphy technique as well as in 3D representation using SPECT. Some of the commonly used radionuclides for the service include Iodine-131, Yttrium-90, Samarium-153, Fluorine-18 and many others.
With the surge in the nuclear medicine imaging industry, the radionuclide scanning services market is also anticipated to increase during the forecast period. Furthermore, wide applications of the technique, painless diagnosis and in-depth analysis results in increasing the market. In most of the developing and under-developed countries, less popularity of the technique and high cost is the restraining factor for the market to grow in. The harmful effects of the radiations also hinders the growth in the diagnosis services market. Lack of skilled personnel for carrying out the diagnostic practices using radionuclide tracers is also a limiting factor in the market growth.
Large number of players in the market increases the competition. R&D activities, continuous innovation and improvisation of the technique also helps in moving the market ahead. Providing safe, cost effective and reliable services is the demand in the market. The brand name of various service providers are attracting the business. Various marketing strategies are adopted by the service providers to lure the doctors and patients for the services.
A geographic condition regarding the radionuclide scanning services market, it has been segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. North America holds the largest market share in the radionuclide scanning services due to large number of service providers in the region, good reimbursement scenario and health facilities in the reach of most of the population. This is followed by Europe because of better healthcare infrastructure and large number of government funded hospitals and laboratories. Asia-Pacific is still considered to be the growing segment because of increasing number of service providers in the region, but does not meet the high population density in the region.
Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/16639
The radionuclide service providers includes the hospitals and private laboratories. Some of the key players in the radionuclide scanning services market include Sonic Healthcare, Aditya Birla Health Services Ltd., Cleveland Clinic, The London Clinic, The GEL Group, Inc., Alliance Medical, Global Diagnostics and many others.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
Telephone - +1-646-568-7751
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radionuclide Scanning Services Market: Global Drivers, Restraints, Opportunities, Trends & Forecast to 2025 here
News-ID: 924746 • Views: …
More Releases from Persistence Market Research

Enameled Cookware Market to Hit $3.5 Bn by 2031 Driven by Durability & Aesthetic …
Overview of the Market
The global enameled cookware market is projected to reach a value of US$ 2.1 Bn in 2024 and is anticipated to expand at a CAGR of 7.3% during the forecast period, achieving a market size of US$ 3.5 Bn by 2031. Enameled cookware, known for its durability, heat resistance, and aesthetic appeal, has gained increasing traction among both professional chefs and household users. Rising consumer preference for…

Bentonite Cat Litter Market to Reach $4.4 Bn by 2031 Driven by Pet Care Trends
Overview of the Market
The global bentonite cat litter market has become a crucial segment of the broader pet care industry, driven by the rising number of pet owners worldwide and the increasing preference for convenient, hygienic, and effective litter solutions. According to market projections, the bentonite cat litter market is expected to reach a value of US$ 3.1 billion in 2024 and expand steadily at a CAGR of 5.2% during…
Microwavable Food Market to Reach $209.1 Bn by 2032, Driven by Convenience & Dem …
Overview of the Market
The global microwavable food market is set for strong growth, with its size projected to be valued at US$ 130.2 billion in 2025 and expected to reach US$ 209.1 billion by 2032, expanding at a CAGR of 7.0% during the forecast period (2025-2032). Microwavable foods, known for their convenience and time-saving attributes, have become a cornerstone of modern lifestyles where urbanization, dual-income households, and busy schedules drive…

Feed Premix Market to Reach $28.3 Bn by 2032 at 9.3% CAGR driven by livestock he …
Overview of the Market
The global feed premix market is poised for substantial expansion in the coming years, driven by the rising demand for nutritionally balanced animal feed. Valued at US$ 15.2 billion in 2025, the market is projected to grow at a CAGR of 9.3% and reach US$ 28.3 billion by 2032. This growth reflects the increasing importance of fortified feed formulations in enhancing livestock health, productivity, and meat quality.…
More Releases for Radionuclide
Radionuclide Drug Conjugates (RDCs) Market Growth Set to Surge Significantly by …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook And Industry Analysis 2031"
The Global Radionuclide Drug Conjugates (RDCs) Market is expected to grow with a CAGR…
Radionuclide Therapy Equipment Market Size And Global Industry Forecast 2034
" In 2024, the global radionuclide therapy equipment market is valued at approximately $4.3 billion, driven by increasing prevalence of cancer and advancements in targeted therapies. The market is projected to reach around $7.8 billion by 2034, reflecting significant growth opportunities primarily attributed to technological advancements, enhanced diagnostic capabilities, and a rising focus on personalized medicine. "
Exactitude Consultancy., Ltd. released a research report titled "Radionuclide Therapy Equipment Market". This report…
Antibody-radionuclide Conjugates Market Share Research Report 2025
On Mar 6, 2025, Global Info Research released a research report titled "Global Antibody-radionuclide Conjugates Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides detailed data analysis of the Antibody-radionuclide Conjugates market from 2020 to 2031. Including the market size and development trends of Antibody-radionuclide Conjugates Market, it analyzes market size indicators such as sales, sales volume, average price and CAGR, it also provides a…
Radionuclide Drug Conjugates (RDCs) Market Robust Expansion is expected to 2031
Radionuclide Drug Conjugates (RDCs) Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook…
Radionuclide Drug Conjugates (RDC) Market Minimizing Side Effects, Maximizing Im …
Radionuclide Drug Conjugates (RDCs) Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook…
Peptide Receptor Radionuclide Therapy Market Analysis, Size, Current Scenario an …
Peptide Receptor Radionuclide Therapy Market is anticipated to grow at a significant CAGR during the forecast period. The increasing prevalence of neuroendocrine tumors is expected to impel the demand for peptide receptor radionuclide therapy (PRRT) as an increasing number of the patient pool. The establishment of reimbursement policies for Lutathera favors the demand for peptide receptor radionuclide therapy (PRRT).
Moreover, increasing clinical trials for the new radiopharmaceuticals drugs approval for cancer…